Curis Lifesciences Limited is an India-based pharmaceutical company. The Company is engaged in the business of manufacturing a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral Liquid, and Sterile Ophthalmic Ointments. The Company manufactures activities on loan license, Contract Manufacturing and Direct Export basis/Own Brand Marketing basis. Its products include general pharmaceutical tablets, general pharmaceutical capsules, general oral liquid, general external preparation, and sterile ophthalmic ointment. Its pharmaceutical tablets are solid dosage form of medication used for delivering active pharmaceutical ingredients. Its sterile ophthalmic ointment is a type of medication formulated for use in the eyes. Its oral liquid is versatile form of medication to be taken by mouth.
CURIS LIFESCIENCES LTD Financial Highlights
- Revenue: CURIS LIFESCIENCES LTD reported revenue of ₹35.89 crore in FY24 vs ₹35.76 crore in FY23. It showed an increase of 0.36% on a yearly basis.
- Operating Profit: CURIS LIFESCIENCES LTD reported an operating profit of ₹7.22 crore in FY24 vs ₹1.54 crore in FY23. It showed an increase of 368.83% on a year-on-year basis.
- Net Profit: CURIS LIFESCIENCES LTD reported a net profit of ₹5.36 crore in FY24 vs ₹1.23 crore in FY23. It showed an increase of 335.77% on a yearly basis.